U.S. Erythropoietin Drugs Market size was USD 4.02 Billion in 2025 and is expected to reach USD 6.18 Billion by 2035 owing to the strong dialysis infrastructure and increasing anemia treatment demand.

A new study published in the journal of BMC Nephrology showed that subcutaneous and intravenous epoetin showed similar ...

Background A 16-year-old white male with a history of obstructive uropathy presented to a pediatric outpatient clinic with a first syncope. At presentation, he had a hemoglobin level of 220 g/l, a ...

Ghaziabad: A 26-year-old man from Meerut received a second chance at life after his mother donated a kidney to him despite ...

Zydus Lifesciences said its Desidustat tablets, licensed to a subsidiary of China Medical System Holdings (CMS), have been approved in China for treating renal anaemia by the National Medical Products ...

Zydus Lifesciences Limited announced that its innovative drug Desidustat tablets, licensed to the subsidiary of China Medical ...

Zydus Lifesciences’ anaemia drug Desidustat receives NMPA approval in China, targeting non-dialysis CKD patients.

Seth Clevenger won yet another Division-III national championship in track and field on Saturday, less than six months after ...

Who would have thought this past weekend’s NCAA Division III Track and Field Championships in Birmingham, Ala., would produce this much drama? After Seth Clevenger of Rowan University won the men’s 5, ...

At altitudes over 2,400 metres, lack of oxygen — a condition called hypoxia — can cause acute mountain sickness. Incidence ...

Phase 2 monotherapy trial of FG-3246, a potential first-in-class antibody drug conjugate (ADC) targeting CD46, in metastatic ...